These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 2021881)
1. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Juniper EF; Guyatt GH Clin Exp Allergy; 1991 Jan; 21(1):77-83. PubMed ID: 2021881 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Juniper EF; Thompson AK; Ferrie PJ; Roberts JN Clin Exp Allergy; 2000 Jan; 30(1):132-40. PubMed ID: 10606940 [TBL] [Abstract][Full Text] [Related]
3. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. Juniper EF; Guyatt GH; Dolovich J J Allergy Clin Immunol; 1994 Feb; 93(2):413-23. PubMed ID: 8120268 [TBL] [Abstract][Full Text] [Related]
4. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. Juniper EF; Thompson AK; Ferrie PJ; Roberts JN J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):364-9. PubMed ID: 10452758 [TBL] [Abstract][Full Text] [Related]
5. [Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)]. Soler R; de la Hoz B; Badia X; Mercadal J; Lozano R; Benavides A; Roset M; Rev Clin Esp; 2004 Mar; 204(3):131-8. PubMed ID: 15025979 [TBL] [Abstract][Full Text] [Related]
6. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Juniper EF; Thompson AK; Roberts JN Allergy; 2002 Mar; 57(3):201-6. PubMed ID: 11906333 [TBL] [Abstract][Full Text] [Related]
7. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. Juniper EF; Guyatt GH; Archer B; Ferrie PJ J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):66-72. PubMed ID: 8335858 [TBL] [Abstract][Full Text] [Related]
8. First-line treatment of seasonal (ragweed) rhinoconjunctivitis. A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine. Juniper EF; Guyatt GH; Ferrie PJ; Griffith LE CMAJ; 1997 Apr; 156(8):1123-31. PubMed ID: 9141982 [TBL] [Abstract][Full Text] [Related]
9. The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis. Röder E; Berger MY; Hop WC; de Groot H; van Wijk RG Pediatr Allergy Immunol; 2013 Feb; 24(1):39-48. PubMed ID: 22882319 [TBL] [Abstract][Full Text] [Related]
10. RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. Liedtke JP; Mandl A; Köther J; Chwieralski J; Shah-Hosseini K; Raskopf E; Pieper-Fürst U; Allekotte S; Mösges R Allergy; 2018 May; 73(5):1101-1109. PubMed ID: 29159975 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Juniper EF; Riis B; Juniper BA Allergy; 2007 Sep; 62(9):1091-3. PubMed ID: 17521314 [TBL] [Abstract][Full Text] [Related]
12. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. Hampel FC; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM Allergy Asthma Proc; 2006; 27(3):202-7. PubMed ID: 16913262 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670 [TBL] [Abstract][Full Text] [Related]
14. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. Juniper EF; Kline PA; Hargreave FE; Dolovich J J Allergy Clin Immunol; 1989 Mar; 83(3):627-33. PubMed ID: 2494249 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis. van Bavel JH; Ratner PH; Amar NJ; Hampel FC; Melchior A; Dunbar SA; Dorinsky PM; Tantry SK Allergy Asthma Proc; 2012; 33(5):386-96. PubMed ID: 23026180 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Meltzer EO; Jacobs RL; LaForce CF; Kelley CL; Dunbar SA; Tantry SK Allergy Asthma Proc; 2012; 33(3):249-57. PubMed ID: 22737708 [TBL] [Abstract][Full Text] [Related]
17. Factors that affect the allergic rhinitis response to ragweed allergen exposure. Ellis AK; Ratz JD; Day AG; Day JH Ann Allergy Asthma Immunol; 2010 Apr; 104(4):293-8. PubMed ID: 20408338 [TBL] [Abstract][Full Text] [Related]
18. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145 [TBL] [Abstract][Full Text] [Related]
19. Measuring quality of life in children with rhinoconjunctivitis. Juniper EF; Howland WC; Roberts NB; Thompson AK; King DR J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):163-70. PubMed ID: 9500748 [TBL] [Abstract][Full Text] [Related]
20. Impact on quality of life during an allergen challenge research trial. Ellis AK; Day JH; Lundie MJ Ann Allergy Asthma Immunol; 1999 Jul; 83(1):33-9. PubMed ID: 10437814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]